Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Michejda

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|December 19, 1998
Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response methodR H Smith, W L Jorgensen, J Tirado-Rives, et al.
Chemical Research in Toxicology|May 11, 1991
1,3-Dialkyltriazenes: reactive intermediates and DNA alkylationM B Kroeger-Koepke, R H Smith, E A Goodnow, et al.
Chemical Research in Toxicology|March 1, 1996
Specificity of DNA alkylation by 1-(2-chloroethyl)-3-alkyl-3-acyltriazenes depends on the structure of the acyl group: kinetic and product studiesM B Smith, B F Schmidt, G Czerwinski, et al.
Chemical Research in Toxicology|November 1, 1990
Stereoselectivity in the microsomal conversion of N-nitrosodimethylamine to formaldehydeL K Keefer, M B Kroeger-Koepke, H Ishizaki, et al.
Journal of Leukocyte Biology|July 17, 1998
Small molecule inhibitor of HIV-1 cell fusion blocks chemokine receptor-mediated functionO M Howard, T Korte, N I Tarasova, et al.
Protein Engineering|May 23, 1998
Molecular modeling of HIV-1 reverse transcriptase drug-resistant mutant strains: implications for the mechanism of polymerase actionM B Kroeger Smith, C J Michejda, S H Hughes, et al.
Biochemical Pharmacology|July 6, 1993
An unexpected pathway for the metabolic degradation of 1,3-dialkyl-3-acyltriazenesC A Rouzer, E J Thompson, T L Skinner, et al.
The Journal of Biological Chemistry|June 6, 1997
Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type AN I Tarasova, R H Stauber, J K Choi, et al.
Chemical Research in Toxicology|January 1, 1996
Oxidative metabolism of 1-(2-chloroethyl)-3-alkyl-3- (methylcarbamoyl)triazenes: formation of chloroacetaldehyde and relevance to biological activityC A Rouzer, M Sabourin, T L Skinner, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcriptionJ A Turpin, R W Buckheit, D Derse, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|December 19, 1998
Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response methodR H Smith, W L Jorgensen, J Tirado-Rives, et al.
Chemical Research in Toxicology|May 11, 1991
1,3-Dialkyltriazenes: reactive intermediates and DNA alkylationM B Kroeger-Koepke, R H Smith, E A Goodnow, et al.
Chemical Research in Toxicology|March 1, 1996
Specificity of DNA alkylation by 1-(2-chloroethyl)-3-alkyl-3-acyltriazenes depends on the structure of the acyl group: kinetic and product studiesM B Smith, B F Schmidt, G Czerwinski, et al.
Chemical Research in Toxicology|November 1, 1990
Stereoselectivity in the microsomal conversion of N-nitrosodimethylamine to formaldehydeL K Keefer, M B Kroeger-Koepke, H Ishizaki, et al.
Journal of Leukocyte Biology|July 17, 1998
Small molecule inhibitor of HIV-1 cell fusion blocks chemokine receptor-mediated functionO M Howard, T Korte, N I Tarasova, et al.
Protein Engineering|May 23, 1998
Molecular modeling of HIV-1 reverse transcriptase drug-resistant mutant strains: implications for the mechanism of polymerase actionM B Kroeger Smith, C J Michejda, S H Hughes, et al.
Biochemical Pharmacology|July 6, 1993
An unexpected pathway for the metabolic degradation of 1,3-dialkyl-3-acyltriazenesC A Rouzer, E J Thompson, T L Skinner, et al.
The Journal of Biological Chemistry|June 6, 1997
Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type AN I Tarasova, R H Stauber, J K Choi, et al.
Chemical Research in Toxicology|January 1, 1996
Oxidative metabolism of 1-(2-chloroethyl)-3-alkyl-3- (methylcarbamoyl)triazenes: formation of chloroacetaldehyde and relevance to biological activityC A Rouzer, M Sabourin, T L Skinner, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcriptionJ A Turpin, R W Buckheit, D Derse, et al.
Pageof 6